Menu

All Activities

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.

Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and CE information More Information

Featured Activity

Equipping Healthcare Professionals with the Necessary Tools for Improving Care in Ovarian Cancer

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.

SHOW SEARCH

Raising the Bar on Sterile Compounding Safety

Activity Downloads

To Participate

To participate in this continuing education activity:

  1. Review the activity description and objectives.
  2. View the activity.
  3. Complete the online post-test and activity evaluation.

Activity Description

Sterile compounding is an essential component of pharmacy practice for pharmacists and pharmacy technicians and efforts to identify and reduce potential adverse events during the preparation of sterile products is imperative to provide safe, optimal patient care.

Over the past 10 years there has been increased growth and maturity in the compounding technology market and an increased uptake by pharmacies in the use of technology during the sterile compounding process. However, despite advancements, a recent ISMP survey on pharmacy compounding systems and practices completed by over 600 practitioners revealed there remains an opportunity to improve the safety of sterile compounding practices as well as increase and enhance the safe use of technology in the process.

In September 2021, The Institute for Safe Medication Practices convened an invitational, virtual sterile compounding safety summit to specifically address safe practices related to the use of robotic compounding automation, sterile compounding workflow software, and automated compounding devices.

Join us for a symposium that will take you from the spark that triggered the summit, through the objectives, targets and structure used to develop new ISMP Best Practice Guidelines, concluding with a discussion of one organization’s journey using various sterile compounding technologies to reduce the risk for errors and the steps they took to minimize threats to safe technology use.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Discuss ISMP survey results regarding sterile compounding.
  • List key areas addressed during a recent sterile compounding safety summit.
  • Describe safety gaps that exist when using technology to support sterile compounding.
  • Identify best practices for the safe use of technology and automation during the compounding process.

Faculty

Introduction and Overview:
Michael R. Cohen, RPh, MS, ScD (hon), DPS (hon), FASHP, President, ISMP

Speaker(s):
Times Change, and We Need to Change with Time
Christina Michalek, BSc, FASHP, Medication Safety Specialist, ISMP

We Know the Target, So How Do We Get There with Safety in Mind?
Rita K. Jew, PharmD, MBA, BCCPS, FASHP, Vice President of Operations, ISMP

Putting Recommendations into Action: Using Compounding Technology Safely
Kevin Hansen, PharmD, MS, BCPS, BCSCP, Assistant Director of Pharmacy: Pharmaceutical Compounding, Residency Program Director: HSPAL, Cone Health Moses H. Cone Memorial Hospital

Disclosure

It is the policy of ProCE, LLC to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed during their presentation. Michael Cohen does not have any relevant commercial and/or financial relationships to disclose. Christina Michalek does not have any relevant commercial and/or financial relationships to disclose. Rita K. Jew has received consulting fees from Omnicell, Bainbridge Health and TB Alliance, and has ownership interest in Arrowhead Pharmaceuticals, Biogen Gilead GSK, Novovax Viking Therapeutics, VaxArt TeleDoc and Amerisource Bergen. Kevin Hansen has received fees for non CE services from Omnicell, Baxter and Analytical Research Labs. Conflicts identified were resolved with a peer review process.

CE Accreditation

Release Date: December 22, 2021
Expiration Date: February 1, 2024

Pharmacists and Pharmacy Technicians

This CE activity is jointly provided by ProCE, LLC and the Institute for Safe Medication Practices (ISMP). ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-21-278-H05-P/T has been assigned to this knowledge-based home-study CE activity. This activity is approved for 1.5 contact hour (0.15 CEU) in states that recognize ACPE providers. This CE activity is provided at no cost to participants. Statements of completion will be issued online at www.ProCE.com upon completion of the evaluation and post-test with a score of 70% or higher. Proof of completion will be posted in NABP CPE Monitor profiles. No partial credit will be given.

Funding

This CE activity is supported by an educational grant from Omnicell.

 

The material presented in this CE activity does not reflect the views of ProCE, LLC or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.